HPV vaccine study targets key groups to boost protection
NCT ID NCT06588257
First seen May 15, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This completed pilot study looked at how acceptable the HPV vaccine is among transgender women and men who have sex with men. Researchers enrolled 101 adults to see how many would start and finish the three-dose vaccine series. The goal is to improve HPV vaccination rates in these communities to help prevent anal HPV infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fundación Huésped
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1427CEA, Argentina
Conditions
Explore the condition pages connected to this study.